Venus Medtech (Hangzhou), Inc. Class H (HK:2500) has released an update.
Venus Medtech (Hangzhou) Inc. successfully conducted its 2024 first extraordinary general meeting and class meetings, wherein all resolutions, except for two, were passed. The meetings saw a 12.93% attendance of the total issued share capital, with key decisions including the appointment of a new Supervisor and approval of amendments to company rules and procedures. The results reflect shareholder support and compliance with PRC laws and corporate statutes.
For further insights into HK:2500 stock, check out TipRanks’ Stock Analysis page.